Medicines
Most widely sold generics first.
- Xeloda capecitabine Advanced breast cancer
- Estradiol tablets estradiol Advanced breast cancer (to ease symptoms)
- Evista raloxifene Lowering the risk of invasive breast cancer after menopause
- Arimidex anastrozole Breast cancer after menopause
- Afinitor everolimus HR-positive, HER2-negative breast cancer after menopause
- Tamoxifen
- Aromasin exemestane Breast cancer after menopause
- Femara letrozole Breast cancer after menopause
- Faslodex fulvestrant Hormone receptor-positive advanced breast cancer
- Halaven eribulin Breast cancer that has spread
- Premarin conjugated estrogens Breast cancer that has spread (to ease symptoms)
- Abraxane paclitaxel Breast cancer that has spread (metastatic)
- Taxotere docetaxel
- Fareston toremifene Breast cancer that has spread, after menopause
- Tykerb lapatinib HER2-positive breast cancer
- Cligavyx fulvestrant · No generic yet Hormone receptor-positive advanced breast cancer
- Cytoxan cyclophosphamide
- Datroway datopotamab deruxtecan · No generic yet Advanced triple-negative breast cancer; Hormone receptor-positive, HER2-negative advanced breast cancer
- Docivyx docetaxel · No generic yet
- Doxorubicin No generic yet
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet HER2-positive breast cancer; HER2-low or HER2-ultralow breast cancer
- Etcamah camizestrant · No generic yet Advanced HR+, HER2- breast cancer when an ESR1 mutation shows up on treatment
- Favlyxa fluorouracil · No generic yet
- Frindovyx cyclophosphamide · No generic yet
- Herceptin trastuzumab · No generic yet HER2-positive breast cancer
- Herceptin Hylecta trastuzumab and hyaluronidase-oysk · No generic yet HER2-positive breast cancer
- Hercessi trastuzumab-strf · No generic yet HER2-positive breast cancer
- Herzuma trastuzumab · No generic yet HER2-positive breast cancer
- Ibrance palbociclib · No generic yet HR-positive, HER2-negative advanced breast cancer; HR-positive, HER2-positive advanced breast cancer
- Inluriyo imlunestrant · No generic yet Advanced ER+, HER2- breast cancer with an ESR1 mutation
- Itovebi inavolisib · No generic yet HR+, HER2- breast cancer with a PIK3CA mutation
- Kadcyla ado-trastuzumab emtansine · No generic yet HER2-positive breast cancer
- Kanjinti trastuzumab-anns · No generic yet HER2-positive breast cancer
- Keytruda pembrolizumab · No generic yet Triple-negative breast cancer
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Triple-negative breast cancer
- Kisqali ribociclib · No generic yet HR-positive, HER2-negative breast cancer
- Lynparza olaparib · No generic yet BRCA-mutated, HER2-negative breast cancer
- Nerlynx neratinib · No generic yet HER2-positive breast cancer
- Ogivri trastuzumab-dkst · No generic yet HER2-positive breast cancer
- Ontruzant trastuzumab · No generic yet HER2-positive breast cancer
- Orserdu elacestrant · No generic yet Advanced ER+, HER2- breast cancer with an ESR1 mutation, after menopause or in men
- Perjeta pertuzumab · No generic yet HER2-positive breast cancer
- Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf · No generic yet HER2-positive breast cancer
- Piqray alpelisib · No generic yet Advanced HR+, HER2- breast cancer with a PIK3CA mutation
- Soltamox tamoxifen · No generic yet Estrogen receptor-positive breast cancer; Lowering the risk of invasive breast cancer after DCIS; Lowering the risk of breast cancer in high-risk women
- Talzenna talazoparib · No generic yet HER2-negative breast cancer with a BRCA gene change
- Trazimera trastuzumab-qyyp · No generic yet HER2-positive breast cancer
- Trodelvy sacituzumab govitecan · No generic yet Triple-negative breast cancer; HR-positive, HER2-negative breast cancer
- Truqap capivasertib · No generic yet HR+, HER2- breast cancer with a PIK3CA, AKT1 or PTEN gene change
- Tukysa tucatinib · No generic yet Advanced HER2-positive breast cancer
- Veppanu vepdegestrant · No generic yet Advanced ER+, HER2- breast cancer with an ESR1 mutation
- Verzenio abemaciclib · No generic yet HR-positive, HER2-negative breast cancer
- Zoladex goserelin · No generic yet Advanced breast cancer before or near menopause